Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Quick Stats
May 22, 202651.1
AI Score
HOLD0.57
Volume Ratio
May 01, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
MRNA Stock Summary
Last updated May 22, 2026
MRNA is currently trading at $46.88, positioned above its 200-day moving average of $37.04, indicating a long-term uptrend. The stock has a 52-week range of $22.28 to $59.55.
Technical Analysis: The 50-day moving average stands at $50.62, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.687, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.202, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MRNA at 51.1/100 with a HOLD recommendation.
MRNA (Moderna, Inc. Common Stock) Indicators
Last updated May 22, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.687 |
| CMF (20) | -0.202 |
| ROC (10) | -13.634 |
| ADX (14) | 18.039 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.848 |
| AROONOSC (14) | 35.714 |
| WILLAMS %R (14) | -90.509 |
| MFI (14) | 56.199 |
MRNA Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MRNA Price vs Max Options Open Interest
MRNA Max Change In Options Open Interest
MRNA Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MRNA Daily Out of Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MRNA Daily In the Money Options - Sort by Max open Interest (near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MRNA Most Active Options by Volume(near term)
22nd May 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Moderna, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MRNA Moving Averages Analysis
Moderna, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on May 22, 2026
MRNA (Moderna, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated May 22, 2026
| Days | MA |
|---|---|
| 10 | 49.17 |
| 20 | 48.51 |
| 30 | 50.15 |
| 50 | 50.62 |
| 100 | 47.63 |
| 200 | 37.04 |
MRNA Fundamental Analysis
| P/E (Forward) | 23.0415 |
| P/E (Trailing) | -- |
| Market Cap ($) | 19.1 billion |
| Earnings/Share ($) | -8.14 |
| Net Proft Margin (%) | -1.4355 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -8.6454 |
| EPS Estimate Next Year ($) | -4.7244 |
| WallStreet Target Price ($) | 43.2 |
| Most Recent Quarter |
News Summary: Moderna's stock price is at a key level on the 4-hour chart, expected to bounce soon. CNBC's Farmer Jim previously pumped the stock but is now quiet. Loading zone for buying is at $26-$27. HHS phases out mRNA vaccine development program. Palantir stock and dips are not a good combination. Questions raised about the effectiveness of mRNA vaccines.
Updated 2025-08-06 19:00:03